FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309659620> ?p ?o ?g. }

• W4309659620 endingPage "6888" @default.
• W4309659620 startingPage "6877" @default.
• W4309659620 abstract "Acute myeloid leukemia (AML) patients with a Fms-like tyrosine kinase 3 (FLT3) mutation have a high incidence of relapse despite allogeneic hematopoietic stem cell transplantation (allo-HSCT) and a subsequent poor prognosis. FLT3 inhibitors (FLT3i) have been suggested to reduce the post-transplant relapse risk in recent studies. As more evidence is accumulated, we perform the present meta-analysis to assess the efficacy and safety of FLT3i as post-transplant maintenance therapy in AML patients.Literature search was performed in public databases from inception to December 31, 2021. Overall survival (OS), relapse-free survival (RFS), cumulative incidence of relapse (CIR), non-relapse mortality (NRM), graft-versus-host disease (GVHD) and adverse events were compared between FLT3i and control groups. Pooled hazard ratio (HR) or relative risk (RR) with corresponding 95% confidence interval (CI) were calculated.We identified 12 eligible studies with 2282 FLT3-mutated AML patients who had received HSCT. There was no between-study heterogeneity and a fix-effect model was used. Post-transplant FLT3i maintenance significantly prolonged OS (HR = 0.41, 95%CI: 0.32-0.52, p < 0.001) and RFS (HR = 0.39, 95%CI 0.31-0.50, p < 0.001), and reduced CIR (HR = 0.31, 95%CI 0.20-0.46, p < 0.001) as compared with control. There were no significant risk differences in NRM (RR = 0.69, 95%CI 0.41-1.17, p = 0.169), acute GVHD (RR = 1.17, 95%CI 0.93-1.47, p = 0.175), chronic GVHD (RR = 1.31, 95%CI 0.91-1.39, p = 0.276) and grade ≥3 adverse events between both groups, except for skin toxicity (RR = 5.86, 95%CI 1.34-25.57, p = 0.019).Post-transplant FLT3i maintenance can improve survival and reduce relapse in FLT3-mutated AML patients and is tolerable." @default.
• W4309659620 created "2022-11-29" @default.
• W4309659620 creator A5024866341 @default.
• W4309659620 creator A5026485153 @default.
• W4309659620 creator A5051339875 @default.
• W4309659620 creator A5062481173 @default.
• W4309659620 date "2022-11-21" @default.
• W4309659620 modified "2023-09-26" @default.
• W4309659620 title "<scp>FLT3</scp> inhibitors as maintenance therapy post allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with <scp>FLT3</scp> mutations: A meta‐analysis" @default.
• W4309659620 cites W1255676896 @default.
• W4309659620 cites W1542395305 @default.
• W4309659620 cites W1569493950 @default.
• W4309659620 cites W1894881392 @default.
• W4309659620 cites W1968306285 @default.
• W4309659620 cites W1971716764 @default.
• W4309659620 cites W1979423827 @default.
• W4309659620 cites W1990924336 @default.
• W4309659620 cites W2016150193 @default.
• W4309659620 cites W2054945577 @default.
• W4309659620 cites W2059150276 @default.
• W4309659620 cites W2108118667 @default.
• W4309659620 cites W2111866362 @default.
• W4309659620 cites W2115707319 @default.
• W4309659620 cites W2129615499 @default.
• W4309659620 cites W2132912591 @default.
• W4309659620 cites W2137691760 @default.
• W4309659620 cites W2138306553 @default.
• W4309659620 cites W2160140526 @default.
• W4309659620 cites W2161102657 @default.
• W4309659620 cites W2272362088 @default.
• W4309659620 cites W2419140434 @default.
• W4309659620 cites W2433943400 @default.
• W4309659620 cites W2502940040 @default.
• W4309659620 cites W2620184199 @default.
• W4309659620 cites W2715749014 @default.
• W4309659620 cites W2765151185 @default.
• W4309659620 cites W2766330759 @default.
• W4309659620 cites W2789864883 @default.
• W4309659620 cites W2880011386 @default.
• W4309659620 cites W2887716600 @default.
• W4309659620 cites W2904378474 @default.
• W4309659620 cites W2917430843 @default.
• W4309659620 cites W2936024454 @default.
• W4309659620 cites W2948900598 @default.
• W4309659620 cites W2982353618 @default.
• W4309659620 cites W3042846071 @default.
• W4309659620 cites W3047616821 @default.
• W4309659620 cites W3047808971 @default.
• W4309659620 cites W3097048433 @default.
• W4309659620 cites W3097277336 @default.
• W4309659620 cites W3111594720 @default.
• W4309659620 cites W3118615836 @default.
• W4309659620 cites W3119843276 @default.
• W4309659620 cites W3125058663 @default.
• W4309659620 cites W3138732253 @default.
• W4309659620 cites W3165988828 @default.
• W4309659620 cites W3183555862 @default.
• W4309659620 cites W3195884454 @default.
• W4309659620 cites W4210559899 @default.
• W4309659620 cites W4284884567 @default.
• W4309659620 doi "https://doi.org/10.1002/cam4.5480" @default.
• W4309659620 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36411731" @default.
• W4309659620 hasPublicationYear "2022" @default.
• W4309659620 type Work @default.
• W4309659620 citedByCount "1" @default.
• W4309659620 countsByYear W43096596202023 @default.
• W4309659620 crossrefType "journal-article" @default.
• W4309659620 hasAuthorship W4309659620A5024866341 @default.
• W4309659620 hasAuthorship W4309659620A5026485153 @default.
• W4309659620 hasAuthorship W4309659620A5051339875 @default.
• W4309659620 hasAuthorship W4309659620A5062481173 @default.
• W4309659620 hasBestOaLocation W43096596201 @default.
• W4309659620 hasConcept C104317684 @default.
• W4309659620 hasConcept C120665830 @default.
• W4309659620 hasConcept C121332964 @default.
• W4309659620 hasConcept C126322002 @default.
• W4309659620 hasConcept C143998085 @default.
• W4309659620 hasConcept C197934379 @default.
• W4309659620 hasConcept C207103383 @default.
• W4309659620 hasConcept C2777408962 @default.
• W4309659620 hasConcept C2778461978 @default.
• W4309659620 hasConcept C2778729363 @default.
• W4309659620 hasConcept C2910954276 @default.
• W4309659620 hasConcept C2911091166 @default.
• W4309659620 hasConcept C44249647 @default.
• W4309659620 hasConcept C501734568 @default.
• W4309659620 hasConcept C50382708 @default.
• W4309659620 hasConcept C55493867 @default.
• W4309659620 hasConcept C61511704 @default.
• W4309659620 hasConcept C71924100 @default.
• W4309659620 hasConcept C82789193 @default.
• W4309659620 hasConcept C86803240 @default.
• W4309659620 hasConcept C88879693 @default.
• W4309659620 hasConceptScore W4309659620C104317684 @default.
• W4309659620 hasConceptScore W4309659620C120665830 @default.
• W4309659620 hasConceptScore W4309659620C121332964 @default.
• W4309659620 hasConceptScore W4309659620C126322002 @default.
• W4309659620 hasConceptScore W4309659620C143998085 @default.

• next